1. Goserelin Acetate (Zoladex)∗with or without Hormone Replacement Therapy for the Treatment of Endometriosis 
Kamran S Moghissi, M.D., William D Schlaff, M.D., David L Olive, M.D., Michael A Skinner, B.S., Helen Yin, M.S. 
Fertility and Sterility 
Volume 69, Issue 6, Pages (June 1998)
DOI: /S (98)

2. FIGURE 1
Mean values for total pelvic symptom score. The decrease in total pelvic symptom score was significantly (P =.011) greater for HRT1 than for the HRT0 or HRT2 at week 12 and significantly (P =.003) less for HRT2 than HRT0 or HRT1 at week 16.
Fertility and Sterility  , DOI: ( /S (98) )

3. FIGURE 2 Mean values for total subjective symptom score.
Fertility and Sterility  , DOI: ( /S (98) )

4. FIGURE 3 Mean value of bone mineral density.
Fertility and Sterility  , DOI: ( /S (98) )

5. FIGURE 4
Mean intensity scores for physiologic side effects of goserelin treatment: (A), Vaginal dryness. (B), Hot flushes. The difference in the mean score as for the HRT1 and HRT2 groups versus the HRT0 group was statistically significant for hot flushes (P <.001) at weeks 12 and 24 and for vaginal dryness (P = .007) at week 24.
Fertility and Sterility  , DOI: ( /S (98) )